Omninet Capital

Omninet Capital, LLC, founded in 1985 and based in California, is an investment firm that focuses on early-stage technology-related companies and value-added investments in commercial and residential real estate across the United States. The firm's principals played a significant role in the establishment of Qualcomm, which has shaped its proactive investment approach. Omninet Ventures, a subsidiary of Omninet Capital, specializes in later-stage investments in communications and internet technologies, targeting companies that generate a minimum of $5 million in annual revenues. The firm does not engage in investments at the development stage, emphasizing its commitment to well-established businesses within its investment portfolio.

http://omninet.com/venture-capital/

http://www.omninet.com

http://www.omninet.com/real_estate/index.html

http://www.omninet.com/venture-capital

https://crunchbase.com/organization/omninet

https://facebook.com/325458094135707

https://linkedin.com/company/omninet-capital

https://pitchbook.com/profiles/investor/11272-69

https://signal.nfx.com/firms/omninet-capital

https://twitter.com/omninetcapital

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=264167

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=34927127

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=34927263

https://www.privateequityinternational.com/database/#/profile?id=13087

Michael Danielpour

Partner

Neil Kadisha

Chief Executive Officer and Managing Partner

David Martin

Chief Financial Officer

Izak Parviz Nazarian

Co-Founder and Managing Partner

Benjamin Nazarian

Managing Partner and Member of the Investment committee

16 past transactions

Three-Building Office Park in Oxnard

Merger/Acquisition in 2019

Three-Building Office Park in Oxnard comprises a real estate properties. The asset is located in Canada.

Plaza Campana

Merger/Acquisition in 2015

Plaza Campana comprises real estate property. The property is located in the United States.

Houston Apartment Complex

Merger/Acquisition in 2015

Houston Apartment Complex comprises apartment homes in Hartford Park. The asset is located in the United States.

Property at 8800 Cal Center Drive

Merger/Acquisition in 2020

Property at 8800 Cal Center Drive comprises two buildings. The asset is located in the United States.

Suburban Office Portfolio in Westlake Village, CA

Merger/Acquisition in 2020

Suburban Office Portfolio in Westlake Village, CA comprises office property portfolio. The asset is located in the United States.

Park Del Amo

Merger/Acquisition in 2020

Park Del Amo comprises a three-building office park. The asset is located in the United States.

Maya Apartments

Merger/Acquisition in 2020

Maya Apartments comprises real estate properties. The asset is located in the United States.

RadLogics

Series A in 2014

RADLogics Inc. develops radiology image analytics software platform for healthcare providers and radiologists. The company develops AlphaPoint, which searches, measures, characterizes, and prepares a preliminary findings report for CT, MRI, ultrasound, and X-ray scans using machine learning image analysis. Its solution uses machine-learning algorithms and takes advantage of accessing, aggregating, and analyzing data from thousands of factual clinical cases to deliver analysis for the case in hand. The company was founded in 2010 and is based in Piedmont, California.

Los Angeles Corporate Center

Merger/Acquisition in 2017

Los Angeles Corporate Center comprises four-building office campus. The asset is located in the United States.

AirPrime

Venture Round in 2002

The company develops code division multiple access chipsets for wireless voice and data products.

Sonics

Series C in 2002

Sonics is a pioneer of network-on-chip (NoC) technology and today offers SoC designers the largest portfolio of intelligent, on-chip communications solutions for home entertainment, wireless, networking and mobile devices. With a broad array of silicon-proven IP, Sonics helps designers eliminate memory bottlenecks associated with complex, high-speed SoC design, streamline and unify data flows and solve persistent network challenges in embedded systems with multiple cores. As the leading supplier of on-chip communications networks for the embedded market, Sonics has enabled its customers to ship more than 750 million units worldwide. Founded in 1996, Sonics is headquartered in Milpitas, Calif. with offices worldwide.

Edeniq

Series A in 2008

Edeniq, Inc. is a leading biotechnology company that develops processes for producing and measuring cellulosic ethanol from corn kernel fiber through its Intellulose technology. Edeniq’s Intellulose requires zero capital investment and is easily integrated into existing ethanol production facilities. Edeniq was established in 2008 and is headquartered in Visalia, Calif. with a field office in Omaha, Neb. More information can be found at www.edeniq.com.

AirPrime

Series C in 2001

The company develops code division multiple access chipsets for wireless voice and data products.

194,908 Square Foot Office Property in Commerce

Merger/Acquisition in 2020

194,908 Square Foot Office Property in Commerce comprises Commerce Plaza, a two-building, 194,908-square-foot office complex. The asset is located in the United States.

Beyond Verbal

Seed Round in 2014

Beyond Verbal is using Voice and AI to extract human emotions and reveal Vocal Biomarkers – acoustic features indicating various health conditions. In collaboration with leading medical institutions, Beyond Verbal performs multiple clinical trials and conducts BIG DATA projects aimed at revealing signs of cardiovascular, pulmonary, neurological and other diseases and chronic medical conditions in the voice – allowing continuous patient monitoring and predictive analytics.

Pattern Bioscience

Series B in 2020

Pattern Bioscience is a privately held in vitro diagnostics company founded in 2016 to help combat the problem of antibiotic resistance. Pattern is developing a next-generation clinical microbiology platform based on its patented phenotypic single-cell technology that can rapidly identify pathogens and determine their antibiotic response without the need for traditional time-consuming culture steps. Pattern’s Digital CultureTM technology relies on functional endpoints that encompass all possible resistance mechanisms, resulting in a more comprehensive and reliable diagnosis compared to rapid genotypic tests. The platform will deliver more reliable diagnoses days faster than the current standard of care.